Skip to content

Galloway Mowat Syndrome 8 C5193045

Published: July 22, 2026Updated: August 20, 2026

A genetic syndrome that impacts brain and kidney function. Usually identified in early childhood with developmental and kidney concerns. Management involves supportive treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spastic tetraplegia

(neurologic)

Severe developmental delay

(neurologic)

Renal dysfunction

(neurologic)

Ophthalmic abnormalities

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Growth and Development Assessment

Serial measurements of growth parameters, developmental milestones, and nutritional status to identify deficits early and guide intervention strategies.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

High-Calorie Nutritional Supplementation

Calorie-dense nutrition and supplementation to address failure to thrive and support adequate growth, often requiring nasogastric or gastrostomy feeds in severe cases.

dietary

Additional treatment options

Gastrostomy Tube Placement

Surgical feeding tube placement when oral intake is insufficient for nutritional needs, providing reliable route for nutrition and medication administration.

procedure

Edema Management

Diuretic therapy and supportive measures to manage fluid retention associated with nephrotic syndrome, monitored carefully to avoid dehydration or electrolyte imbalance.

medication

Gentle Complementary Therapies

Supportive complementary approaches such as therapeutic touch, music therapy, and aromatherapy to enhance comfort and quality of life for patients with severe illness.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Galloway Mowat Syndrome 8 C5193045?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Galloway Mowat Syndrome 8 C5193045. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy